▶ 調査レポート

エリスロポエチンの世界及び中国市場

• 英文タイトル:Global and China Erythropoietin Market Insights, Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。エリスロポエチンの世界及び中国市場 / Global and China Erythropoietin Market Insights, Forecast to 2027 / QY2108PAL8821資料のイメージです。• レポートコード:QY2108PAL8821
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(納期:1日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の当調査資料ではグローバルにおけるエリスロポエチンの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、エリスロポエチンの種類別市場規模(エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他)、用途別市場規模(貧血、腎障害、その他)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のエリスロポエチン市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるエリスロポエチンの種類別市場規模(2016年-2027年):エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他
・世界におけるエリスロポエチンの用途別市場規模(2016年-2027年):貧血、腎障害、その他
・エリスロポエチンの中国市場分析
- エリスロポエチンの中国市場規模(2016年-2027年)
- 中国におけるエリスロポエチンの主要プレイヤー別市場シェア
- 中国におけるエリスロポエチンの種類別市場規模:エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他
- 中国におけるエリスロポエチンの用途別市場規模:貧血、腎障害、その他
・エリスロポエチンの北米市場(2016年-2027年)
・エリスロポエチンのヨーロッパ市場(2016年-2027年)
・エリスロポエチンのアジア太平洋市場(2016年-2027年)
・エリスロポエチンの中南米市場(2016年-2027年)
・エリスロポエチンの中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

Market Analysis and Insights: Global and China Erythropoietin Market
This report focuses on global and China Erythropoietin market.
In 2020, the global Erythropoietin market size was US$ 8657 million and it is expected to reach US$ 12840 million by the end of 2027, with a CAGR of 5.8% during 2021-2027. In China the Erythropoietin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Erythropoietin Scope and Market Size
Erythropoietin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Erythropoietin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Erythropoietin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Segment by Application
Anemia
Kidney Disorders
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

レポート目次

1 Study Coverage
1.1 Erythropoietin Product Introduction
1.2 Market by Type
1.2.1 Global Erythropoietin Market Size Growth Rate by Type
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Market by Application
1.3.1 Global Erythropoietin Market Size Growth Rate by Application
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Erythropoietin Market Size, Estimates and Forecasts
2.1.1 Global Erythropoietin Revenue 2016-2027
2.1.2 Global Erythropoietin Sales 2016-2027
2.2 Global Erythropoietin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Erythropoietin Historical Market Size by Region (2016-2021)
2.3.1 Global Erythropoietin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Erythropoietin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Erythropoietin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Erythropoietin Sales Forecast by Region (2022-2027)
2.4.2 Global Erythropoietin Revenue Forecast by Region (2022-2027)

3 Global Erythropoietin Competitor Landscape by Players
3.1 Global Top Erythropoietin Manufacturers by Sales
3.1.1 Global Erythropoietin Sales by Manufacturer (2016-2021)
3.1.2 Global Erythropoietin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Erythropoietin Manufacturers by Revenue
3.2.1 Key Erythropoietin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Erythropoietin Revenue by Manufacturers (2016-2021)
3.2.3 Global Erythropoietin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Erythropoietin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Erythropoietin Revenue in 2020
3.2.6 Global Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Erythropoietin Price by Manufacturers
3.4 Global Erythropoietin Manufacturing Base Distribution, Product Types
3.4.1 Erythropoietin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Erythropoietin Product Type
3.4.3 Date of International Manufacturers Enter into Erythropoietin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Erythropoietin Market Size by Type (2016-2021)
4.1.1 Global Erythropoietin Sales by Type (2016-2021)
4.1.2 Global Erythropoietin Revenue by Type (2016-2021)
4.1.3 Erythropoietin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Erythropoietin Market Size Forecast by Type (2022-2027)
4.2.1 Global Erythropoietin Sales Forecast by Type (2022-2027)
4.2.2 Global Erythropoietin Revenue Forecast by Type (2022-2027)
4.2.3 Erythropoietin Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Erythropoietin Market Size by Application (2016-2021)
5.1.1 Global Erythropoietin Sales by Application (2016-2021)
5.1.2 Global Erythropoietin Revenue by Application (2016-2021)
5.1.3 Erythropoietin Price by Application (2016-2021)
5.2 Erythropoietin Market Size Forecast by Application (2022-2027)
5.2.1 Global Erythropoietin Sales Forecast by Application (2022-2027)
5.2.2 Global Erythropoietin Revenue Forecast by Application (2022-2027)
5.2.3 Global Erythropoietin Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Erythropoietin Market Size YoY Growth 2016-2027
6.1.1 China Erythropoietin Sales YoY Growth 2016-2027
6.1.2 China Erythropoietin Revenue YoY Growth 2016-2027
6.1.3 China Erythropoietin Market Share in Global Market 2016-2027
6.2 China Erythropoietin Market Size by Players (International and Local Players)
6.2.1 China Top Erythropoietin Players by Sales (2016-2021)
6.2.2 China Top Erythropoietin Players by Revenue (2016-2021)
6.3 China Erythropoietin Historic Market Review by Type (2016-2021)
6.3.1 China Erythropoietin Sales Market Share by Type (2016-2021)
6.3.2 China Erythropoietin Revenue Market Share by Type (2016-2021)
6.3.3 China Erythropoietin Price by Type (2016-2021)
6.4 China Erythropoietin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Erythropoietin Sales Forecast by Type (2022-2027)
6.4.2 China Erythropoietin Revenue Forecast by Type (2022-2027)
6.4.3 China Erythropoietin Price Forecast by Type (2022-2027)
6.5 China Erythropoietin Historic Market Review by Application (2016-2021)
6.5.1 China Erythropoietin Sales Market Share by Application (2016-2021)
6.5.2 China Erythropoietin Revenue Market Share by Application (2016-2021)
6.5.3 China Erythropoietin Price by Application (2016-2021)
6.6 China Erythropoietin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Erythropoietin Sales Forecast by Application (2022-2027)
6.6.2 China Erythropoietin Revenue Forecast by Application (2022-2027)
6.6.3 China Erythropoietin Price Forecast by Application (2022-2027)

7 North America
7.1 North America Erythropoietin Market Size YoY Growth 2016-2027
7.2 North America Erythropoietin Market Facts & Figures by Country
7.2.1 North America Erythropoietin Sales by Country (2016-2021)
7.2.2 North America Erythropoietin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Erythropoietin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Erythropoietin Market Facts & Figures by Region
8.2.1 Asia Pacific Erythropoietin Sales by Region (2016-2021)
8.2.2 Asia Pacific Erythropoietin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Erythropoietin Market Size YoY Growth 2016-2027
9.2 Europe Erythropoietin Market Facts & Figures by Country
9.2.1 Europe Erythropoietin Sales by Country (2016-2021)
9.2.2 Europe Erythropoietin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Erythropoietin Market Size YoY Growth 2016-2027
10.2 Latin America Erythropoietin Market Facts & Figures by Country
10.2.1 Latin America Erythropoietin Sales by Country (2016-2021)
10.2.2 Latin America Erythropoietin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Erythropoietin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Erythropoietin Market Facts & Figures by Country
11.2.1 Middle East and Africa Erythropoietin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Erythropoietin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Description and Business Overview
12.1.3 Amgen Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Erythropoietin Products Offered
12.1.5 Amgen Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Description and Business Overview
12.2.3 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Erythropoietin Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Erythropoietin Products Offered
12.3.5 Roche Recent Development
12.4 Galenica
12.4.1 Galenica Corporation Information
12.4.2 Galenica Description and Business Overview
12.4.3 Galenica Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Galenica Erythropoietin Products Offered
12.4.5 Galenica Recent Development
12.5 Emcure
12.5.1 Emcure Corporation Information
12.5.2 Emcure Description and Business Overview
12.5.3 Emcure Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Emcure Erythropoietin Products Offered
12.5.5 Emcure Recent Development
12.6 Kyowa Hakko Kirin
12.6.1 Kyowa Hakko Kirin Corporation Information
12.6.2 Kyowa Hakko Kirin Description and Business Overview
12.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Kyowa Hakko Kirin Erythropoietin Products Offered
12.6.5 Kyowa Hakko Kirin Recent Development
12.7 3SBio
12.7.1 3SBio Corporation Information
12.7.2 3SBio Description and Business Overview
12.7.3 3SBio Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 3SBio Erythropoietin Products Offered
12.7.5 3SBio Recent Development
12.8 Biocon
12.8.1 Biocon Corporation Information
12.8.2 Biocon Description and Business Overview
12.8.3 Biocon Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biocon Erythropoietin Products Offered
12.8.5 Biocon Recent Development
12.9 LG Life Sciences
12.9.1 LG Life Sciences Corporation Information
12.9.2 LG Life Sciences Description and Business Overview
12.9.3 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 LG Life Sciences Erythropoietin Products Offered
12.9.5 LG Life Sciences Recent Development
12.11 Amgen
12.11.1 Amgen Corporation Information
12.11.2 Amgen Description and Business Overview
12.11.3 Amgen Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Amgen Erythropoietin Products Offered
12.11.5 Amgen Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Erythropoietin Industry Trends
13.2 Erythropoietin Market Drivers
13.3 Erythropoietin Market Challenges
13.4 Erythropoietin Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Erythropoietin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Erythropoietin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Epoetin-alfa
Table 3. Major Manufacturers of Epoetin-beta
Table 4. Major Manufacturers of Darbepoetin-alfa
Table 5. Major Manufacturers of Others
Table 6. Global Erythropoietin Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 7. Global Erythropoietin Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Erythropoietin Sales by Regions (2016-2021) & (M Units)
Table 9. Global Erythropoietin Sales Market Share by Regions (2016-2021)
Table 10. Global Erythropoietin Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Erythropoietin Sales Forecast by Region (2022-2027) & (M Units)
Table 12. Global Erythropoietin Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Erythropoietin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Erythropoietin Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Erythropoietin Sales by Manufacturers (2016-2021) (M Units)
Table 16. Global Erythropoietin Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Erythropoietin Manufacturers by Revenue (US$ Million) in 2020
Table 18. Erythropoietin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Erythropoietin Revenue Share by Manufacturers (2016-2021)
Table 20. Global Erythropoietin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Erythropoietin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin as of 2020)
Table 22. Key Manufacturers Erythropoietin Price (2016-2021) (US$/Unit)
Table 23. Erythropoietin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Erythropoietin Product Type
Table 25. Date of International Manufacturers Enter into Erythropoietin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Erythropoietin Sales by Type (2016-2021) (M Units)
Table 28. Global Erythropoietin Sales Share by Type (2016-2021)
Table 29. Global Erythropoietin Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Erythropoietin Revenue Share by Type (2016-2021)
Table 31. Erythropoietin Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Erythropoietin Sales Forecast by Type (2022-2027) & (M Units)
Table 33. Global Erythropoietin Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Erythropoietin Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Erythropoietin Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Erythropoietin Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Erythropoietin Sales by Application (2016-2021) (M Units)
Table 38. Global Erythropoietin Sales Share by Application (2016-2021)
Table 39. Global Erythropoietin Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Erythropoietin Revenue Share by Application (2016-2021)
Table 41. Erythropoietin Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Erythropoietin Sales Forecast by Application (2022-2027) & (M Units)
Table 43. Global Erythropoietin Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Erythropoietin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Erythropoietin Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Erythropoietin Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. China Erythropoietin Sales (M Units) of Key Companies (2016-2021)
Table 48. China Erythropoietin Sales Share by Company (2016-2021)
Table 49. China Erythropoietin Revenue (US$ Million) by Company (2016-2021)
Table 50. China Erythropoietin Revenue Share by Company (2016-2021)
Table 51. China Erythropoietin Sales (M Units) by Type (2016-2021)
Table 52. China Erythropoietin Sales Share by Type (2016-2021)
Table 53. China Erythropoietin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Erythropoietin Price (US$/Unit) by Type (2016-2021)
Table 55. China Erythropoietin Sales (M Units) by Type (2022-2027)
Table 56. China Erythropoietin Sales Share by Type (2022-2027)
Table 57. China Erythropoietin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Erythropoietin Revenue Share by Type (2022-2027)
Table 59. China Erythropoietin Price (US$/Unit) by Type (2022-2027)
Table 60. China Erythropoietin Sales (M Units) by Application (2016-2021)
Table 61. China Erythropoietin Sales Share by Application (2016-2021)
Table 62. China Erythropoietin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Erythropoietin Price (US$/Unit) by Application (2016-2021)
Table 64. China Erythropoietin Sales (M Units) by Application (2022-2027)
Table 65. China Erythropoietin Sales Share by Application (2022-2027)
Table 66. China Erythropoietin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Erythropoietin Revenue Share by Application (2022-2027)
Table 68. China Erythropoietin Price (US$/Unit) by Application (2022-2027)
Table 69. North America Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 70. North America Erythropoietin Sales Market Share by Country (2016-2021)
Table 71. North America Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Erythropoietin Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Erythropoietin Sales by Region (2016-2021) & (M Units)
Table 74. Asia Pacific Erythropoietin Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Erythropoietin Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Erythropoietin Revenue Market Share by Region (2016-2021)
Table 77. Europe Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 78. Europe Erythropoietin Sales Market Share by Country (2016-2021)
Table 79. Europe Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Erythropoietin Revenue Market Share by Country (2016-2021)
Table 81. Latin America Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 82. Latin America Erythropoietin Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Erythropoietin Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 86. Middle East and Africa Erythropoietin Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Erythropoietin Revenue Market Share by Country (2016-2021)
Table 89. Amgen Corporation Information
Table 90. Amgen Description and Business Overview
Table 91. Amgen Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. Amgen Erythropoietin Product
Table 93. Amgen Recent Development
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Description and Business Overview
Table 96. Johnson & Johnson Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. Johnson & Johnson Product
Table 98. Johnson & Johnson Recent Development
Table 99. Roche Corporation Information
Table 100. Roche Description and Business Overview
Table 101. Roche Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Roche Product
Table 103. Roche Recent Development
Table 104. Galenica Corporation Information
Table 105. Galenica Description and Business Overview
Table 106. Galenica Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. Galenica Product
Table 108. Galenica Recent Development
Table 109. Emcure Corporation Information
Table 110. Emcure Description and Business Overview
Table 111. Emcure Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Emcure Product
Table 113. Emcure Recent Development
Table 114. Kyowa Hakko Kirin Corporation Information
Table 115. Kyowa Hakko Kirin Description and Business Overview
Table 116. Kyowa Hakko Kirin Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Kyowa Hakko Kirin Product
Table 118. Kyowa Hakko Kirin Recent Development
Table 119. 3SBio Corporation Information
Table 120. 3SBio Description and Business Overview
Table 121. 3SBio Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. 3SBio Product
Table 123. 3SBio Recent Development
Table 124. Biocon Corporation Information
Table 125. Biocon Description and Business Overview
Table 126. Biocon Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. Biocon Product
Table 128. Biocon Recent Development
Table 129. LG Life Sciences Corporation Information
Table 130. LG Life Sciences Description and Business Overview
Table 131. LG Life Sciences Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. LG Life Sciences Product
Table 133. LG Life Sciences Recent Development
Table 134. Erythropoietin Market Trends
Table 135. Erythropoietin Market Drivers
Table 136. Erythropoietin Market Challenges
Table 137. Erythropoietin Market Restraints
Table 138. Erythropoietin Customers List
Table 139. Erythropoietin Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Erythropoietin Product Picture
Figure 2. Global Erythropoietin Sales Market Share by Type in 2020 & 2027
Figure 3. Epoetin-alfa Product Picture
Figure 4. Epoetin-beta Product Picture
Figure 5. Darbepoetin-alfa Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erythropoietin Sales Market Share by Application in 2020 & 2027
Figure 8. Anemia
Figure 9. Kidney Disorders
Figure 10. Others
Figure 11. Erythropoietin Report Years Considered
Figure 12. Global Erythropoietin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Erythropoietin Market Size 2016-2027 (US$ Million)
Figure 14. Global Erythropoietin Sales 2016-2027 (M Units)
Figure 15. Global Erythropoietin Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Erythropoietin Sales Market Share by Region (2016-2021)
Figure 17. Global Erythropoietin Sales Market Share by Region in 2020
Figure 18. Global Erythropoietin Revenue Market Share by Region (2016-2021)
Figure 19. Global Erythropoietin Revenue Market Share by Region in 2020
Figure 20. Global Erythropoietin Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Erythropoietin Revenue in 2020
Figure 22. Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Erythropoietin Sales Market Share by Type (2016-2021)
Figure 24. Global Erythropoietin Sales Market Share by Type in 2020
Figure 25. Global Erythropoietin Revenue Market Share by Type (2016-2021)
Figure 26. Global Erythropoietin Revenue Market Share by Type in 2020
Figure 27. Global Erythropoietin Sales Market Share by Application (2016-2021)
Figure 28. Global Erythropoietin Sales Market Share by Application in 2020
Figure 29. Global Erythropoietin Revenue Market Share by Application (2016-2021)
Figure 30. Global Erythropoietin Revenue Market Share by Application in 2020
Figure 31. China Erythropoietin Sales Growth Rate 2016-2027 (M Units)
Figure 32. China Erythropoietin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Erythropoietin Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Erythropoietin Players Market Share by Revenue in Erythropoietin in 2020
Figure 35. China Erythropoietin Revenue Share by Type (2016-2021)
Figure 36. China Erythropoietin Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Erythropoietin Revenue Share by Application (2016-2021)
Figure 38. China Erythropoietin Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Erythropoietin Sales Growth Rate 2016-2021 (M Units)
Figure 40. North America Erythropoietin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Erythropoietin Sales Market Share by Country in 2020
Figure 42. North America Erythropoietin Revenue Market Share by Country in 2020
Figure 43. U.S. Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 44. U.S. Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 46. Canada Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Erythropoietin Sales Growth Rate 2016-2021 (M Units)
Figure 48. Europe Erythropoietin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Erythropoietin Sales Market Share by Country in 2020
Figure 50. Europe Erythropoietin Revenue Market Share by Country in 2020
Figure 51. Germany Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 52. Germany Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 54. France Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 56. U.K. Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 58. Italy Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 60. Russia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Erythropoietin Sales Growth Rate 2016-2021 (M Units)
Figure 62. Asia Pacific Erythropoietin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Erythropoietin Sales Market Share by Region in 2020
Figure 64. Asia Pacific Erythropoietin Revenue Market Share by Region in 2020
Figure 65. China Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 66. China Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 68. Japan Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 70. South Korea Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 72. India Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 74. Australia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. China Taiwan Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 76. China Taiwan Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 78. Indonesia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 80. Thailand Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 82. Malaysia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Latin America Erythropoietin Sales Growth Rate 2016-2021 (M Units)
Figure 84. Latin America Erythropoietin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 85. Latin America Erythropoietin Sales Market Share by Country in 2020
Figure 86. Latin America Erythropoietin Revenue Market Share by Country in 2020
Figure 87. Mexico Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 88. Mexico Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Brazil Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 90. Brazil Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Argentina Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 92. Argentina Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Erythropoietin Sales Growth Rate 2016-2021 (M Units)
Figure 94. Middle East and Africa Erythropoietin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Erythropoietin Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Erythropoietin Revenue Market Share by Country in 2020
Figure 97. Turkey Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 98. Turkey Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 100. Saudi Arabia Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Erythropoietin Sales Growth Rate (2016-2021) (M Units)
Figure 102. UAE Erythropoietin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Erythropoietin Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed